Philip Comp to Protein C
This is a "connection" page, showing publications Philip Comp has written about Protein C.
Connection Strength
1.060
-
Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002 Nov; 126(11):1337-48.
Score: 0.204
-
Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. Thromb Res. 2015 Dec; 136(6):1120-5.
Score: 0.125
-
Blockade of protein C activation reduces microvascular surgical blood loss. J Surg Res. 1992 Jun; 52(6):560-4.
Score: 0.099
-
Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation. 1991 Mar; 51(3):701-5.
Score: 0.091
-
Analysis of protein C and protein S in disease states. Dev Biol Stand. 1987; 67:75-82.
Score: 0.068
-
Anticoagulation proteins C and S. Adv Exp Med Biol. 1987; 214:47-54.
Score: 0.068
-
Clinical implications of the protein C/protein S system. Ann N Y Acad Sci. 1987; 509:149-55.
Score: 0.068
-
Hereditary disorders predisposing to thrombosis. Prog Hemost Thromb. 1986; 8:71-102.
Score: 0.063
-
Advances in the etiology and treatment of venous thromboembolism. Adv Intern Med. 1999; 44:59-89.
Score: 0.039
-
On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 1995 Jan; 95(1):309-16.
Score: 0.030
-
Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol. 1992 Oct; 167(4 Pt 2):1184-91.
Score: 0.025
-
Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest. 1988 May; 81(5):1445-54.
Score: 0.019
-
The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304.
Score: 0.016
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.015
-
Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13; 311(24):1525-8.
Score: 0.015
-
Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec; 74(6):2082-8.
Score: 0.015
-
Animal studies of protein C physiology. Semin Thromb Hemost. 1984 Apr; 10(2):149-53.
Score: 0.014
-
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004 Apr; 8(2):R82-90.
Score: 0.014
-
Heparin-protein C interaction. Nouv Rev Fr Hematol. 1984; 26(4):239-42.
Score: 0.014
-
The activation and effects of protein C, an antithrombotic protein, in vivo. Surv Synth Pathol Res. 1984; 3(1):31-7.
Score: 0.014
-
Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21.
Score: 0.014
-
Activation of protein C in vivo. J Clin Invest. 1982 Jul; 70(1):127-34.
Score: 0.012
-
Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest. 1981 Nov; 68(5):1221-8.
Score: 0.012
-
Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986 Feb; 77(2):416-25.
Score: 0.004
-
Biochemical and physiological aspects of protein c. Ric Clin Lab. 1984 Jul-Sep; 14(3):455-68.
Score: 0.004